ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Milano, Lombardia

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Stomach Cancer
Adenocarcinoma
Ovarian Cancer
Neoplasm Metastasis

Pancreatic Cancer trials near Milano, Lombardia, ITA:

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 2

Astellas
Astellas

Milan, Italy and 135 other locations

Status recently updated

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...

Enrolling
Active, not recruiting
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 1

Amgen
Amgen

Milan, Italy and 76 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Milano, Lombardia, Italy and 91 other locations

cancer, gastroesophageal junction cancer (GEJ cancer) or pancreatic cancer. GEJ is where the tube that ...

Enrolling
Pancreatic Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Drug: Irinotecan
Drug: Leucovorin

Phase 1

Astellas
Astellas

Milan, Italy and 45 other locations

Conjugate M9140 in Participants with Advanced Non-Small Cell Lung Cancer (Substudy NSCLC);* PROCEADE PanTumor: A Phase 1b/2, Multicenter, O ...

Active, not recruiting
Gastric Cancer
Non-Small Cell Lung Cancer (NSCLC)
Drug: M9140

Phase 1, Phase 2

Merck KGaA (EMD Serono)
Merck KGaA (EMD Serono)

Milan, Italy and 80 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Active, not recruiting
PDAC - Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Milan, Italy and 59 other locations

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Active, not recruiting
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Milan, Italy and 67 other locations

The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...

Enrolling
Uterine Cervical Neoplasms
Ovarian Neoplasms
Drug: carboplatin
Drug: LY4170156

Phase 1

Lilly
Lilly

Milan, Italy and 23 other locations

BOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially d...

Enrolling
Gastric Cancers
Pancreatic Cancer
Drug: BOLD-100 +/- FOLFOX Chemotherapy (Arm VII)
Drug: BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI)

Phase 1, Phase 2

Bold Therapeutics

Milan, Italy and 23 other locations

to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...

Active, not recruiting
Pancreatic Cancer Harboring NRG1 Fusion
NSCLC Harboring NRG1 Fusion
Drug: zenocutuzumab (MCLA-128)

Phase 2

Partner Therapeutics

Milan, Italy and 64 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems